These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8922045)

  • 1. Application of mapping of cardiac electrical activity to the pharmacology.
    D'Alché EP
    Acta Cardiol; 1996; 51(5):381-94. PubMed ID: 8922045
    [No Abstract]   [Full Text] [Related]  

  • 2. The electrophysiology of Norpace (Part I).
    Dreifus LS
    Angiology; 1975 Jan; 26(1 Pt 2):111-5. PubMed ID: 1115397
    [No Abstract]   [Full Text] [Related]  

  • 3. Adverse effects of disopyramide (Norpace): toxic interactions with other antiarrhythmic agents.
    Ellrodt G; Singh BN
    Heart Lung; 1980; 9(3):469-74. PubMed ID: 6901519
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessment with potential mapping of the cardiac protective effect of a drug. Example of trimetazidine.
    d'Alché P; Clauser P; Morel M; Gauthier V
    J Pharmacol Methods; 1991 Aug; 26(1):43-51. PubMed ID: 1921407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of trimetazidine on myocardial preconditioning in anesthetized rats.
    Kara AF; Demiryürek S; Celik A; Tarakçioğlu M; Demiryürek AT
    Eur J Pharmacol; 2004 Oct; 503(1-3):135-45. PubMed ID: 15496308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacology of Norpace.
    Dean RR
    Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
    [No Abstract]   [Full Text] [Related]  

  • 7. [In vitro study, in perfused rabbit heart, of interaction between two anti-arrhythmia agents: amiodarone and disopyramide].
    Akhdim H; Kantelip JP; Stimmesse B; Toubin G; Magnin P
    C R Seances Soc Biol Fil; 1990; 184(5-6):329-34. PubMed ID: 2151805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative effect of imolamine, lidocaine and disopyramide on experimental rhythm disorders and auriculoventricular conduction.
    Junien JL; Lakatos CR; Tine J
    Arzneimittelforschung; 1974 Nov; 24(11):1743-7. PubMed ID: 4141258
    [No Abstract]   [Full Text] [Related]  

  • 9. [Possibilities of clinical pharmacology in the evaluation of anti-arrhythmia and anti-angina drugs].
    Mazur NA; Metelitsa VI
    Farmakol Toksikol; 1982; 45(3):59-63. PubMed ID: 7095129
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical pharmacology of antiarrhythmic agents.
    Graboys TB
    Heart Lung; 1979; 8(4):706-10. PubMed ID: 256558
    [No Abstract]   [Full Text] [Related]  

  • 11. The actions of verapamil on experimental arrhythmias.
    Rodrigues-Pereira E; Viana AP
    Arzneimittelforschung; 1968 Feb; 18(2):175-9. PubMed ID: 5695375
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of the effects of disopyramide and hydroquinidine in animals].
    Lisin N; Carlier J
    Arch Mal Coeur Vaiss; 1973 Oct; 66(10):1329-35. PubMed ID: 4207476
    [No Abstract]   [Full Text] [Related]  

  • 13. Disopyramide: although potentially life-threatening in the setting of long QT, could it be life-saving in short QT syndrome?
    Dumaine R; Antzelevitch C
    J Mol Cell Cardiol; 2006 Sep; 41(3):421-3. PubMed ID: 16863649
    [No Abstract]   [Full Text] [Related]  

  • 14. [Myocardial cytoprotection with trimetazidine in patients with ischemic heart disease during surgical stress].
    Afanas'eva IV; Goncharova LL; Miroshnichenko AG; Petrash VV; Pokrovskaia LA
    Vestn Khir Im I I Grek; 1999; 158(5):34-7. PubMed ID: 10645577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Proceedings: Anti-arrhythmic action of disopyramide].
    Nakamura T; Takahashi K; Niitani U; Sugiura T; Miyaji K
    Jpn Circ J; 1975 Apr; 39(4):497. PubMed ID: 1121090
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative comparison of the anticholinergic and antiarrhytmic actions of disopyramide and quinidine.
    Pérez A; Ledea N; Hermández K; Garcia-Barreto D
    Pol J Pharmacol Pharm; 1977; 29(5):527-32. PubMed ID: 593967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of atropine, propafenon and disopyramide on "sino-atrial conduction time" in man].
    Breithardt G; Seipel L; Both A; Loogen F
    Verh Dtsch Ges Inn Med; 1975; 81():1634-7. PubMed ID: 1227042
    [No Abstract]   [Full Text] [Related]  

  • 18. [Time correlation of the cardiac electric field on the body surface and depolarization sequences in the pigeon heart ventricle epicardium].
    Kharin SN; Roshchevskaia IM; Shmakov DN; Roshchevskiĭ MP
    Ross Fiziol Zh Im I M Sechenova; 2000 Dec; 86(12):1604-11. PubMed ID: 11212512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effect of trimetazidine on myocardial mitochondrial function in an ex-vivo model of global myocardial ischemia.
    Monteiro P; Duarte AI; Gonçalves LM; Moreno A; Providência LA
    Eur J Pharmacol; 2004 Oct; 503(1-3):123-8. PubMed ID: 15496306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational basis of antiarrhythmic therapy: clinical pharmacology of commonly used antiarrhythmic drugs.
    Singh BN
    Angiology; 1978 Mar; 29(3):206-42. PubMed ID: 347988
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.